The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Campbell David Alan | President and CEO, Director | Option exercise(M) | 7K | — | $0 |
| Jul 8, 2026 | Campbell David Alan | President and CEO, Director | Option exercise(M) | 7K | $4.21 | $29K |
| Jun 11, 2026 | Simson Jake | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Simson Jake | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Kung Winston | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Kung Winston | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Hernday Natasha | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Hernday Natasha | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Dobmeier Eric | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Dobmeier Eric | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Capps Vickie L | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Capps Vickie L | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Barrett Ronald W | Director | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Barrett Ronald W | Director | Grant(A) | 16K | — | $0 |
| Jun 11, 2026 | Ra Capital Management, L.P. | Director, 10% Owner | Grant(A) | 6K | — | $0 |
| Jun 11, 2026 | Ra Capital Management, L.P. | Director, 10% Owner | Grant(A) | 16K | — | $0 |
| Jun 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Sell(S) | 4K | $14.03 | $57K |
| May 11, 2026 | Dobek Maria | Vice President, Accounting | Sell(S) | 2K | $14.17 | $29K |
| Feb 2, 2026 | Go William | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Feb 2, 2026 | Go William | Chief Medical Officer | Grant(A) | 154K | — | $0 |
| Jan 2, 2026 | Dobek Maria | Vice President, Accounting | Grant(A) | 19K | — | $0 |
| Jan 2, 2026 | Dobek Maria | Vice President, Accounting | Sell(S) | 1K | $13.73 | $20K |
| Jan 2, 2026 | Dobek Maria | Vice President, Accounting | Grant(A) | 43K | — | $0 |
| Jan 2, 2026 | Campbell David Alan | President and CEO, Director | Grant(A) | 97K | — | $0 |
| Jan 2, 2026 | Campbell David Alan | President and CEO, Director | Sell(S) | 8K | $13.73 | $111K |
| Jan 2, 2026 | Campbell David Alan | President and CEO, Director | Grant(A) | 338K | — | $0 |
| Jan 2, 2026 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 2K | $13.73 | $26K |
| Jan 2, 2026 | Winter Charles M. | Chief Technical Officer | Grant(A) | 29K | — | $0 |
| Jan 2, 2026 | Winter Charles M. | Chief Technical Officer | Sell(S) | 2K | $13.73 | $33K |
| Jan 2, 2026 | Winter Charles M. | Chief Technical Officer | Grant(A) | 100K | — | $0 |
| Jan 2, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Sell(S) | 3K | $13.73 | $34K |
| Jan 2, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Grant(A) | 31K | — | $0 |
| Jan 2, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Grant(A) | 110K | — | $0 |
| Jan 2, 2026 | McIver Zachariah | Chief Medical Officer | Grant(A) | 29K | — | $0 |
| Jan 2, 2026 | McIver Zachariah | Chief Medical Officer | Sell(S) | 3K | $13.73 | $37K |
| Jan 2, 2026 | McIver Zachariah | Chief Medical Officer | Grant(A) | 102K | — | $0 |
| Jan 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Grant(A) | 36K | — | $0 |
| Jan 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Grant(A) | 126K | — | $0 |
| Dec 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 633 | $33.52 | $21K |
| Dec 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $32.85 | $89K |
| Dec 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $10.59 | $35K |
| Dec 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Nov 14, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $30.00 | $100K |
| Nov 14, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $10.59 | $35K |
| Nov 14, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Oct 28, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 17K | $30.06 | $501K |
| Oct 28, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 10K | $4.21 | $42K |
| Oct 28, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 7K | $10.59 | $71K |
| Oct 28, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 7K | — | $0 |
| Oct 28, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 10K | — | $0 |
| Jun 11, 2025 | Kung Winston | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Kung Winston | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Simson Jake | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Simson Jake | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | McNulty Alana B. | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | McNulty Alana B. | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Hernday Natasha | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Hernday Natasha | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Gujrathi Sheila | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Gujrathi Sheila | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Dobmeier Eric | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Dobmeier Eric | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Capps Vickie L | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Capps Vickie L | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | Barrett Ronald W | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | Barrett Ronald W | Director | Grant(A) | 12K | — | $0 |
| Jun 11, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Jun 11, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Grant(A) | 12K | — | $0 |
| Jun 2, 2025 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Grant(A) | 44K | — | $0 |
| Jun 2, 2025 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Grant(A) | 154K | — | $0 |
| May 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 400 | $32.60 | $13K |
| May 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $31.95 | $94K |
| May 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $4.21 | $14K |
| May 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Apr 21, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $30.00 | $100K |
| Apr 21, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $4.21 | $14K |
| Apr 21, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Mar 7, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy(P) | 110K | $31.02 | $3.4M |
| Mar 6, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy(P) | 372K | $30.78 | $11.5M |
| Mar 5, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy(P) | 304K | $30.56 | $9.3M |
| Mar 5, 2025 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy(P) | 37K | $31.30 | $1.2M |
| Mar 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $4.21 | $14K |
| Mar 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 901 | $32.85 | $30K |
| Mar 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 2K | $31.88 | $78K |
| Mar 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Feb 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 100 | $43.60 | $4K |
| Feb 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 816 | $42.77 | $35K |
| Feb 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 2K | $42.08 | $102K |
| Feb 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | $4.21 | $14K |
| Feb 3, 2025 | Meyer Andrew Hollman | Chief Business Officer | Option exercise(M) | 3K | — | $0 |
| Jan 7, 2025 | Campbell David Alan | President and CEO, Director | Sell(S) | 5K | $60.00 | $300K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 6K | $54.51 | $314K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $53.76 | $157K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Grant(A) | 18K | — | $0 |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 1K | $56.78 | $57K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 3K | $55.76 | $192K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell(S) | 200 | $57.37 | $11K |
| Jan 2, 2025 | Meyer Andrew Hollman | Chief Business Officer | Grant(A) | 63K | — | $0 |
| Jan 2, 2025 | Dobek Maria | Vice President, Accounting | Grant(A) | 14K | — | $0 |
| Jan 2, 2025 | Dobek Maria | Vice President, Accounting | Grant(A) | 32K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).